North America. For the assessment of traditional herbal

drugs, Lloyd noted correctly:

(CFR) under the regulatory authority of the Food and Drug Administration (FDA). To paraphrase federal regulations, an adulteration is any component of a product whose identity is not as disclosed or whose quality is such that the material value of the product is compromised in any way in terms of quality, purity, or safety (Table 3.1). In botanical products, adulterations can include complete or partial substitution of one botanical for another, excessive amounts of impurities such as foreign matter (e.g., dirt, twigs, insect fragments), deteriorated or substandard material, contaminants (e.g., excessive microbial contamination), or any condition that would otherwise lessen the claimed or expected value of the product.